US FDA Approves First-Line Use of Boehringer Ingelheim’s Lung Cancer Drug
The US Food and Drug Administration (FDA) has approved the first-line use of Boehringer Ingelheim’s lung cancer therapy zongertinib for […]
BOEHRINGER-INGELHEIMS-LUNG-CANCER-THERAPY
